Anton Roth

1.2k total citations · 1 hit paper
24 papers, 935 citations indexed

About

Anton Roth is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Anton Roth has authored 24 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in Anton Roth's work include Gastric Cancer Management and Outcomes (5 papers), Esophageal Cancer Research and Treatment (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Anton Roth is often cited by papers focused on Gastric Cancer Management and Outcomes (5 papers), Esophageal Cancer Research and Treatment (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Anton Roth collaborates with scholars based in Poland, United States and Slovenia. Anton Roth's co-authors include Krsto Kolarić, Marek Pawlicki, George Manikhas, M. Biakhov, Э К Возный, Tadeusz Pieńkowski, Sergei Tjulandin, José Baselga, Xiangyang Liu and Brian Leyland‐Jones and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Chemotherapy and Pharmacology.

In The Last Decade

Anton Roth

23 papers receiving 877 citations

Hit Papers

Maintaining Normal Hemoglobin Levels With Epoetin Alfa in... 2005 2026 2012 2019 2005 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Maintaining Normal Hemoglobin Levels With Epoetin Alfa in Mainly Nonanemic Patients With Metastatic Breast Cancer Receiving First-Line Chemotherapy: A Survival Study
    2005 505 citations Brian Leyland‐Jones, Semiglazov Vf et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anton Roth Poland 14 455 363 190 160 118 24 935
G. A. T. Hawson Australia 11 182 0.4× 136 0.4× 166 0.9× 196 1.2× 87 0.7× 24 664
Tommie Mynster Denmark 13 152 0.3× 259 0.7× 95 0.5× 264 1.6× 43 0.4× 41 727
Antonio Marrazzo Italy 14 129 0.3× 282 0.8× 116 0.6× 133 0.8× 76 0.6× 39 724
Vicenta Martı́nez-Sales Spain 17 188 0.4× 110 0.3× 157 0.8× 133 0.8× 96 0.8× 45 827
Gail Jones United Kingdom 18 750 1.6× 224 0.6× 281 1.5× 53 0.3× 275 2.3× 32 1.4k
B Bizzi Italy 20 877 1.9× 150 0.4× 144 0.8× 117 0.7× 388 3.3× 97 1.3k
Cheng S. Quah United States 14 182 0.4× 540 1.5× 363 1.9× 224 1.4× 451 3.8× 30 1.3k
I. A. Cooper Australia 13 275 0.6× 110 0.3× 66 0.3× 48 0.3× 140 1.2× 27 636
Anwar Tarabichi Germany 14 95 0.2× 401 1.1× 224 1.2× 196 1.2× 40 0.3× 19 786
M. Neil Reaume Canada 18 162 0.4× 461 1.3× 642 3.4× 234 1.5× 39 0.3× 66 1.1k

Countries citing papers authored by Anton Roth

Since Specialization
Citations

This map shows the geographic impact of Anton Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton Roth more than expected).

Fields of papers citing papers by Anton Roth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anton Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton Roth. The network helps show where Anton Roth may publish in the future.

Co-authorship network of co-authors of Anton Roth

This figure shows the co-authorship network connecting the top 25 collaborators of Anton Roth. A scholar is included among the top collaborators of Anton Roth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anton Roth. Anton Roth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roth, Anton. (2016). Extraction of energy and time from pile-up pulses with fast sampling ADC analysis techniques. Lund University Publications Student Papers (Lund University). 1 indexed citations
2.
Leyland‐Jones, Brian, Semiglazov Vf, Marek Pawlicki, et al.. (2005). Maintaining Normal Hemoglobin Levels With Epoetin Alfa in Mainly Nonanemic Patients With Metastatic Breast Cancer Receiving First-Line Chemotherapy: A Survival Study. Journal of Clinical Oncology. 23(25). 5960–5972. 505 indexed citations breakdown →
3.
Roth, Anton, et al.. (1999). High Doses of 5-Fluorouracil and Epirubicin with or without Cisplatin in Advanced Gastric Cancer: A Randomized Study. Tumori Journal. 85(4). 234–238. 24 indexed citations
4.
Pawlicki, Marek, Jacek Jassem, P Bõsze, et al.. (1997). A multicenter study of recombinant human erythropoietin (epoetin α) in the management of anemia in cancer patients receiving chemotherapy. Anti-Cancer Drugs. 8(10). 949–957. 14 indexed citations
5.
Roth, Anton, et al.. (1990). Open Phase II with 5-Fluorouracil, 4-Epi-Doxorubicin and Mitomycin C (Fem) in Advanced Gastric Cancer. Tumori Journal. 76(1). 51–53. 6 indexed citations
6.
Roth, Anton & Krsto Kolarić. (1987). Analgesic activity of calcitonin in patients with painful osteolytic metastases of breast cancer. European Journal of Cancer and Clinical Oncology. 23(11). 1795–1795. 14 indexed citations
7.
8.
Roth, Anton & Krsto Kolarić. (1985). Treatment of Disseminated Testicular Tumors with Combination of Cis-Platinum, Vinblastine, Bleomycin and Actinomycin D. Oncology. 42(4). 248–252. 1 indexed citations
9.
Kolarić, Krsto, et al.. (1984). The Value of Two Combined Chemoradiotherapy Approaches in the Treatment of Inoperable Esophageal Cancer. Tumori Journal. 70(1). 69–75. 3 indexed citations
10.
11.
Kolarić, Krsto & Anton Roth. (1983). Methylprednisolone as an Antiemetic in Patients on Cis-Platinum Chemotherapy. Results of a Controlled Randomized Study. Tumori Journal. 69(1). 43–46. 8 indexed citations
12.
Kolarić, Krsto, et al.. (1981). Preliminary Report on Antitumorigenic Activity of CIS-Dichlorodiamine Platinum in Metastatic Brain Tumors. Tumori Journal. 67(5). 483–486. 6 indexed citations
13.
Roth, Anton, et al.. (1980). Iron, copper, and zinc liver tissue levels in patients with malignant lymphomas. Cancer. 46(3). 565–569. 20 indexed citations
14.
15.
Kolarić, Krsto, et al.. (1980). Bleomycin Infusions Combined with Radiotherapy in the Treatment of Inoperable Esophageal Cancer. Tumori Journal. 66(5). 615–621. 4 indexed citations
16.
17.
Kolarić, Krsto, et al.. (1978). Combination Chemotherapy with 1-Methyl-1-Nitrosourea and Cyclophosphamide in Metastatic Melanoma. Tumori Journal. 64(1). 89–94. 2 indexed citations
18.
Roth, Anton, Krsto Kolarić, & Mara Dominis. (1978). Histologic and Cytologic Liver Changes in 120 Patients with Malignant Lymphomas. Tumori Journal. 64(1). 45–53. 14 indexed citations
19.
Kolarić, Krsto, et al.. (1977). Adriamycin Alone and in Combination with Radiotherapy in the Treatment of Inoperable Esophageal Cancer. Tumori Journal. 63(5). 485–491. 21 indexed citations
20.
Kolarić, Krsto, et al.. (1976). Therapy of Advanced Esophageal Cancer with Bleomycin, Irradiation and Combination of Bleomycin with Irradiation. Tumori Journal. 62(3). 255–262. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. A. T. Hawson Breakdown of academic impact, for papers by Tommie Mynster Breakdown of academic impact, for papers by Antonio Marrazzo Breakdown of academic impact, for papers by Vicenta Martı́nez-Sales Breakdown of academic impact, for papers by Gail Jones Breakdown of academic impact, for papers by B Bizzi Breakdown of academic impact, for papers by Cheng S. Quah Breakdown of academic impact, for papers by I. A. Cooper Breakdown of academic impact, for papers by Anwar Tarabichi Breakdown of academic impact, for papers by M. Neil Reaume
Rankless by CCL
2026